Skip to main content
. 2022 Nov 29;109(1):129–137. doi: 10.1177/03008916221138881

Figure 2.

Figure 2.

Waterfall plot of Best Response to Cabozantinib

The confirmed ORR was 37.9% (95%CI: 20.7-57.7%). 11 patients achieved a partial response to cabozantinib as best response, 13 disease stability, while 2 patients progressed. Of the four patients not evaluable, three patients died due to clinical disease progression before radiological staging.